The discussion explores the concept of divergent evolution, particularly how hemoglobin remains consistent across species due to its efficiency. In contrast, antibodies exhibit a high degree of variability, especially in their complementary determining regions (CDRs), complicating predictions about their shapes. This variability highlights the challenge in software development for analyzing antibody data, emphasizing the need for a different approach compared to more stable proteins like hemoglobin.
